收费全文 | 41762篇 |
免费 | 1994篇 |
国内免费 | 192篇 |
耳鼻咽喉 | 691篇 |
儿科学 | 700篇 |
妇产科学 | 743篇 |
基础医学 | 5443篇 |
口腔科学 | 1241篇 |
临床医学 | 2965篇 |
内科学 | 9800篇 |
皮肤病学 | 644篇 |
神经病学 | 3448篇 |
特种医学 | 1417篇 |
外科学 | 7131篇 |
综合类 | 188篇 |
一般理论 | 3篇 |
预防医学 | 1557篇 |
眼科学 | 640篇 |
药学 | 3498篇 |
中国医学 | 87篇 |
肿瘤学 | 3752篇 |
2023年 | 215篇 |
2022年 | 426篇 |
2021年 | 757篇 |
2020年 | 375篇 |
2019年 | 529篇 |
2018年 | 650篇 |
2017年 | 485篇 |
2016年 | 600篇 |
2015年 | 624篇 |
2014年 | 840篇 |
2013年 | 1097篇 |
2012年 | 1748篇 |
2011年 | 1891篇 |
2010年 | 1086篇 |
2009年 | 931篇 |
2008年 | 1792篇 |
2007年 | 1926篇 |
2006年 | 1890篇 |
2005年 | 1825篇 |
2004年 | 1782篇 |
2003年 | 1810篇 |
2002年 | 1748篇 |
2001年 | 1618篇 |
2000年 | 1774篇 |
1999年 | 1501篇 |
1998年 | 484篇 |
1997年 | 390篇 |
1996年 | 364篇 |
1995年 | 303篇 |
1994年 | 284篇 |
1993年 | 250篇 |
1992年 | 1107篇 |
1991年 | 921篇 |
1990年 | 901篇 |
1989年 | 943篇 |
1988年 | 833篇 |
1987年 | 832篇 |
1986年 | 782篇 |
1985年 | 769篇 |
1984年 | 528篇 |
1983年 | 423篇 |
1982年 | 217篇 |
1979年 | 482篇 |
1978年 | 274篇 |
1977年 | 251篇 |
1975年 | 207篇 |
1974年 | 223篇 |
1971年 | 230篇 |
1969年 | 230篇 |
1968年 | 216篇 |
Research design and methods: This multicenter, open-label, single-group, prospective interventional study evaluated changes in total gait-related scores of the Part II/III Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and Freezing of Gait Questionnaire (FOG-Q) in 31 Parkinson’s disease patients treated with istradefylline. Gait analysis by portable gait rhythmogram was performed.
Results: MDS-UPDRS Part III gait-related total scores significantly decreased at Weeks 4–12 from baseline with significant improvements in gait, freezing of gait, and postural stability. Significant decreases in MDS-UPDRS Part II total scores and individual item scores at Week 12 indicated improved daily living activities. At Week 12, there were significant improvements in FOG-Q, new FOG-Q, and overall movement per 48 h measured by portable gait rhythmogram. Adverse events occurred in 7/31 patients.
Conclusions: Istradefylline improved gait disorders in Parkinson’s disease patients complicated with freezing of gait, improving their quality of life. No unexpected adverse drug reactions were identified.
Trial registration: UMIN-CTR (UMIN000020288). 相似文献
![点击此处可从《Journal of the European Academy of Dermatology and Venereology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
![点击此处可从《Journal of the European Academy of Dermatology and Venereology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Methods: Individuals who visited the outpatient clinic or were admitted to the palliative care unit were eligible. Patients with a performance status of 4 and/or those unable to complete questionnaires were excluded. PA was evaluated using a bioanalyzer device. The correlation coefficient between PA and the variables of interest was analyzed.
Results: A total of 102 patients were analyzed. PA was weakly correlated with age (ρ = ?0.22), performance status (ρ = ?0.30), functional well-being (ρ?=?0.20), anorexia/cachexia subscale (ρ?=?0.22), and Functional Assessment of Anorexia/Cachexia Therapy trial outcome index (ρ?=?0.26). PA was also correlated with fluid retention (ρ = ?0.34) and albumin (ρ?=?0.32), C-reactive protein (ρ = ?0.31), and hemoglobin (ρ?=?0.41) levels. Sub-analysis stratified according to sex revealed that males demonstrated the same results; however, female sex demonstrated a correlation between PA and social well-being (ρ = ?0.43).
Conclusions: PA was correlated with physical condition, but not with psychological well-being. 相似文献